News
Atrial fibrillation (AF) represents an important public health problem, with patients having an increased long-term risk of stroke, heart failure and all-cause death. Although antiarrhythmic drugs ...
Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to late breaking research presented in a ...
In July 2025, Medtronic Cardiac Rhythm and Heart Failure conducted a study is to demonstrate the efficiency on AT / AF ...
Pulsed field ablation (PFA) was noninferior to cryoballoon ablation for the incidence of a first recurrence of atrial tachyarrhythmia among patients with symptomatic paroxysmal atrial fibrillation ...
Drug therapy is currently the standard first-line treatment for patients with atrial fibrillation (AF); however, AF recurs in approximately half of patients treated with AADs within a year of ...
Background Atrial fibrillation (AF) is the most common sustained atrial arrhythmia, is more common in men and the prevalence increases with increasing age. [2] AF can be paroxysmal (episodes ...
Boston Scientific announced it received FDA approval for its navigation-enabled ablation catheter for the treatment of paroxysmal atrial fibrillation and 510 (k) clearance for new imaging software ...
Indeed, both the 2014 AHA/ACC/HRS guidelines and the 2020 ESC guidelines for management of atrial fibrillation state that ablation can be considered as a first-line approach in patients with ...
Catheter ablation of paroxysmal atrial fibrillation (AF) is being employed with increasing frequency, although the relative clinical effects of this procedure when compared with antiarrhythmic ...
SAN FRANCISCO, July 26, 2022 (GLOBE NEWSWIRE) -- InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing inhaled therapies for cardiovascular diseases ...
The treatment helps patients with paroxysmal atrial fibrillation, an intermittent form of atrial fibrillation that causes the irregular heart rate. “The new POLARx cryoablation system is yet ...
FARAPULSE Receives European Approval To Commercialize Its Leading Pulsed Field Ablation System To Treat Paroxysmal Atrial Fibrillation PRESS RELEASE PR Newswire Jan. 29, 2021, 03:30 AM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results